12:53 PM
 | 
Oct 13, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Rare endocrine play Spruce emerges from stealth and announces $20M series A

On Oct. 12, Spruce Biosciences Inc. (San Francisco, Calif.) revealed a $20 million series A round of funding and said it has begun enrolling patients in a U.S. Phase...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >